Recent Finacing
Recent Raise
Darwin Biological (Beijing) develops stem cell, immune cell, and exosome-based biologics and biomaterials employing ECIWEP targeted protein extraction, producing a Class I neuro-repair biologic and cartilage-repair consumables.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors